Sofpironium Targets M3 Receptors In Vitro and Shows Early Clinically Meaningful Improvement in Primary Axillary Hyperhidrosis Symptoms. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s717, 2025. DOI: 10.25251/kvstvq23. Disponível em: https://skin.dermsquared.com/skin/article/view/3770. Acesso em: 14 jan. 2026.